Antibody engineering to develop new antirheumatic therapies

por Isaacs, John D
Publicado 2009

Tolerising cellular therapies: what is their promise for autoimmune disease?

por Mosanya, Chijioke H, Isaacs, John D
Publicado 2019

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs

por Isaacs, John D, Burmester, Gerd R
Publicado 2020

“Living a normal life”: a qualitative study of patients’ views of medication withdrawal in rheumatoid arthritis

por Baker, Kenneth F., Isaacs, John D., Thompson, Ben
Publicado 2019

Current concepts in the pathogenesis of early rheumatoid arthritis

por Pratt, Arthur G., Isaacs, John D., Mattey, Derek L.
Publicado 2009

Basic Mechanisms of JAK Inhibition

por Lin, Chung MA, Cooles, Faye AH, Isaacs, John D.
Publicado 2020

Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis

por Isaacs, John D, Harari, Olivier, Kobold, Uwe, Lee, Janet S, Bernasconi, Corrado
Publicado 2013

What can rheumatologists learn from translational cancer therapy?

por Sherlock, Jonathan P, Filer, Andrew D, Isaacs, John D, Buckley, Christopher D
Publicado 2013

Drug breakthrough offers hope to arthritis sufferers: qualitative analysis of medical research in UK newspapers

por Hanson, Helen, O'Brien, Nicola, Whybrow, Paul, Isaacs, John D, Rapley, Tim
Publicado 2016

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis

por Harry, Rachel A, Anderson, Amy E, Isaacs, John D, Hilkens, Catharien M U
Publicado 2010

Tolerogenic dendritic cells differentially modulate naïve and memory CD4(+ )T cells

por Anderson, Amy E, Sayers, Bethan, Diboll, Julie, Isaacs, John D, Hilkens, Catharien MU
Publicado 2007

Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?

por Pratt, Arthur G, Lorenzi, Alice R, Wilson, Gill, Platt, Philip N, Isaacs, John D
Publicado 2013

Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data

por Pratt, Arthur G., Lendrem, Dennis, Hargreaves, Ben, Aslam, Osman, Galloway, James B., Isaacs, John D.
Publicado 2016

Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

por Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.
Publicado 2019

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

por Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.
Publicado 2020

Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?

por Busby, Amanda D, Wason, James, Pratt, Arthur G, Young, Adam, Isaacs, John D, Nikiphorou, Elena
Publicado 2021

The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data

por Busby, Amanda D, Wason, James, Pratt, Arthur G, Young, Adam, Isaacs, John D, Nikiphorou, Elena
Publicado 2022

Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remission

por Baker, Kenneth F., Thompson, Ben, Lendrem, Dennis W., Scadeng, Adam, Pratt, Arthur G., Isaacs, John D.
Publicado 2020

Integrated safety in tocilizumab clinical trials

por Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F
Publicado 2011

Disease activity and cognition in rheumatoid arthritis: an open label pilot study

por Raftery, Graham, He, Jiabao, Pearce, Ruth, Birchall, Daniel, Newton, Julia L, Blamire, Andrew M, Isaacs, John D
Publicado 2012